Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BASTION: Brincidofovir for BK Virus in Kidney Transplant Recipients
NCT05511779Phase 2Terminated
- Sponsor
- SymBio Pharmaceuticals
- Start
- Oct 2022
- Primary completion
- Apr 2023
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of brincidofovir in BK virus infection, sponsored by SymBio Pharmaceuticals. Started Oct 2022; status: terminated.
02
Drugs
brincidofovir
03
Conditions
BK virus infection
Beyond the preview
Go deeper on NCT05511779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05511779.